Bezisterim

DB05212InvestigationalSmall molecule

For the treatment of rheumatoid arthritis and type 2 diabetes.

Chemical structure of Bezisterim
Mechanism
Curator reviewed
Primary indication
For the treatment of rheumatoid arthritis and type 2 diabetes.Curator reviewed
Formula / weight
C21H30O3 · 330.468 g/mol (avg)
Code names
HE-3286 · NE3107

Resolves to

Structure
InChIKeyJJKOQZHWYLMASZ-FJWDNACWSA-NSMILES[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](O)C=C2C[C@@H](O)CC[C@]12C

What you can answer from here — as of September 13, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
109Drug interactionsStructured to mechanism, not free text
Sign in
10Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Bezisterim, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account